Literature DB >> 8781389

Environmental toxicants in developing countries.

P Ostrosky-Wegman1, M E Gonsebatt.   

Abstract

Health effects from environmental toxicants may be a more serious problem in developing countries compared with developed countries because the problem is potentiated by other factors: a) the lack of or failure to enforce regulations, which allows human exposures to genotoxic agents; b) undernourishment of the lower economic and social classes that comprise the most exposed populations from industrial and agricultural activities; and c) parasitic infections that afflict a wide range of populations in both urban and rural areas. Data on the genotoxic effects of different types of exposures, including environmental exposes (natural and industrial), occupational exposures, and infections and medical treatments, are presented and discussed with the point of view that all these factors must be taken into account with respect to regulation and the protection of human health. Occupational exposures in developing countries are higher than in developed countries due to lack of stringent regulations, lack of knowledge of the risks involved, and the negligence of workers. General pollution is another important issue since developed countries have established strict regulations and risky industrial processes are being exported to developing countries, along with banned substances and dangerous industrial wastes. It should be emphasized that stringent regulations in developed countries will not prevent exposures in the long term because toxic substances that are released into the environment will ultimately reach all our future generations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781389      PMCID: PMC1469635          DOI: 10.1289/ehp.96104s3599

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  23 in total

1.  Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies.

Authors:  A Flisser; D Gonzalez; A Plancarte; P Ostrosky; R Montero; A Stephano; D Correa
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

2.  [Immunosuppression T-lymphocytes in swine, modulated by Cysticercus cellulosae].

Authors:  J L Molinar; P Tato; Y Valles
Journal:  Rev Latinoam Microbiol       Date:  1987 Jul-Sep

3.  [Effect of immunization in immunodepressed pigs naturally parasitized by Cysticercus cellulosae].

Authors:  P Tato; Y Valles; R Rolón; J L Molinari
Journal:  Rev Latinoam Microbiol       Date:  1987 Jan-Mar

4.  Depressive effect of a Taenia solium cysticercus factor on cultured human lymphocytes stimulated with phytohaemagglutinin.

Authors:  J L Molinari; P Tato; O A Reynoso; J M Cázares
Journal:  Ann Trop Med Parasitol       Date:  1990-06

5.  AS-101: a modulator of in vitro T-cell proliferation.

Authors:  R Montero; M E Gonsebatt; R Gerson; E Rojas; L A Herrera; P Ostrosky-Wegman
Journal:  Anticancer Drugs       Date:  1993-06       Impact factor: 2.248

6.  Mutagenicity of antiamebic and anthelmintic drugs in the Salmonella typhimurium microsomal test system.

Authors:  C Cortinas de Nava; J Espinosa; L García; A M Zapata; E Martínez
Journal:  Mutat Res       Date:  1983-04       Impact factor: 2.433

7.  Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico.

Authors:  P Ostrosky-Wegman; M E Gonsebatt; R Montero; L Vega; H Barba; J Espinosa; A Palao; C Cortinas; G García-Vargas; L M del Razo
Journal:  Mutat Res       Date:  1991 Sep-Oct       Impact factor: 2.433

8.  Evaluation of spleen lymphocyte responsiveness to a T-cell mitogen during early infection with larval Taenia taeniaeformis.

Authors:  T Letonja; C Hammerberg; G Schurig
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

9.  Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.

Authors:  M S Cetron; F P Basilio; A P Moraes; A Q Sousa; J N Paes; S J Kahn; M H Wener; W C Van Voorhis
Journal:  Am J Trop Med Hyg       Date:  1993-09       Impact factor: 2.345

10.  Human cysticercosis: antigens, antibodies and non-responders.

Authors:  A Flisser; E Woodhouse; C Larralde
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

View more
  1 in total

1.  A retired shipyard worker with rapidly progressive pulmonary interstitial fibrosis.

Authors:  E V Moy; H Hu; D C Christiani
Journal:  Environ Health Perspect       Date:  1999-04       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.